Concord Biotech informs about analyst meet outcome

15 Nov 2025 Evaluate
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to intimation dated November 8, 2025 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for Second Quarter and half year ended September 30, 2025, Concord Biotech has informed that the said Earning Call was held on 14th November, 2025 at 03:30 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: https://concordbiotech.com/wp-content/uploads/2025/11/Q2FY26-EarningCall-Audio.mp3

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1347.60 -2.95 (-0.22%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×